Cargando…

Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease

Alzheimer’s disease (AD) patients exhibit olfactory dysfunction. However, the olfactory declineti precise nature is not fully understood. One hundred patients (60 AD, 28 amnestic mild cognitive impairment (aMCI), 12 Normal) were enrolled. All participants underwent olfactory function testing using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda-Kameyama, Yumi, Ishii, Shinya, Kameyama, Masashi, Kondo, Kenji, Ochi, Atsushi, Yamasoba, Tatsuya, Ogawa, Sumito, Akishita, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500500/
https://www.ncbi.nlm.nih.gov/pubmed/28684764
http://dx.doi.org/10.1038/s41598-017-05201-7
_version_ 1783248638808424448
author Umeda-Kameyama, Yumi
Ishii, Shinya
Kameyama, Masashi
Kondo, Kenji
Ochi, Atsushi
Yamasoba, Tatsuya
Ogawa, Sumito
Akishita, Masahiro
author_facet Umeda-Kameyama, Yumi
Ishii, Shinya
Kameyama, Masashi
Kondo, Kenji
Ochi, Atsushi
Yamasoba, Tatsuya
Ogawa, Sumito
Akishita, Masahiro
author_sort Umeda-Kameyama, Yumi
collection PubMed
description Alzheimer’s disease (AD) patients exhibit olfactory dysfunction. However, the olfactory declineti precise nature is not fully understood. One hundred patients (60 AD, 28 amnestic mild cognitive impairment (aMCI), 12 Normal) were enrolled. All participants underwent olfactory function testing using an odour stick identification test for Japanese (OSIT-J). OSIT-J scores were significantly correlated with recall. We classified OSIT-J odorants into three groups: Category I, odorants that were difficult for normal aged subjects to identify; Category II, odorants that became harder to accurately identify with cognitive decline; and Category III, odorants that even AD patients could identify. We defined a “cognitive subset” consisting of six Category II OSIT-J odorants (perfume, rose, Japanese cypress, curry, India ink and gas leak odour). The ability to identify “cognitive subset” odours was significantly better indicator of cognitive status than the ability to identify “non-cognitive subset”, which consisted of the six remaining items. The ability to identify the gas leak odorant was decreased early in the aMCI stage, suggesting a need to reconsider the odours used to signal gas leaks. The “cognitive subset” would provide a more convenient and effective biomarker for diagnosing dementia in clinical settings.
format Online
Article
Text
id pubmed-5500500
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55005002017-07-10 Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease Umeda-Kameyama, Yumi Ishii, Shinya Kameyama, Masashi Kondo, Kenji Ochi, Atsushi Yamasoba, Tatsuya Ogawa, Sumito Akishita, Masahiro Sci Rep Article Alzheimer’s disease (AD) patients exhibit olfactory dysfunction. However, the olfactory declineti precise nature is not fully understood. One hundred patients (60 AD, 28 amnestic mild cognitive impairment (aMCI), 12 Normal) were enrolled. All participants underwent olfactory function testing using an odour stick identification test for Japanese (OSIT-J). OSIT-J scores were significantly correlated with recall. We classified OSIT-J odorants into three groups: Category I, odorants that were difficult for normal aged subjects to identify; Category II, odorants that became harder to accurately identify with cognitive decline; and Category III, odorants that even AD patients could identify. We defined a “cognitive subset” consisting of six Category II OSIT-J odorants (perfume, rose, Japanese cypress, curry, India ink and gas leak odour). The ability to identify “cognitive subset” odours was significantly better indicator of cognitive status than the ability to identify “non-cognitive subset”, which consisted of the six remaining items. The ability to identify the gas leak odorant was decreased early in the aMCI stage, suggesting a need to reconsider the odours used to signal gas leaks. The “cognitive subset” would provide a more convenient and effective biomarker for diagnosing dementia in clinical settings. Nature Publishing Group UK 2017-07-06 /pmc/articles/PMC5500500/ /pubmed/28684764 http://dx.doi.org/10.1038/s41598-017-05201-7 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Umeda-Kameyama, Yumi
Ishii, Shinya
Kameyama, Masashi
Kondo, Kenji
Ochi, Atsushi
Yamasoba, Tatsuya
Ogawa, Sumito
Akishita, Masahiro
Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title_full Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title_fullStr Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title_full_unstemmed Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title_short Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
title_sort heterogeneity of odorant identification impairment in patients with alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500500/
https://www.ncbi.nlm.nih.gov/pubmed/28684764
http://dx.doi.org/10.1038/s41598-017-05201-7
work_keys_str_mv AT umedakameyamayumi heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT ishiishinya heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT kameyamamasashi heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT kondokenji heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT ochiatsushi heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT yamasobatatsuya heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT ogawasumito heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease
AT akishitamasahiro heterogeneityofodorantidentificationimpairmentinpatientswithalzheimersdisease